Hinge Health

HNGE

Market cap $4.54B

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced the results of the most comprehensive medical claims analysis of its digital musculoskeletal (MSK) solution, demonstrating an average cost savings of $2,941 per member per year using its chronic MSK program and a 3.0x ROI for employers and health plans. With a rigorous methodology independently reviewed by Howden, a global leading benefits consultant, the study dwarfs all prior ROI studies in digital MSK. It analyze.

Hinge Health continues to outperform expectations and strengthen its growth trajectory each quarter. Despite notable volatility in HNGE's share price, the company's operational momentum is increasingly hard to ignore. Recent performance suggests HNGE is building a compelling investment case, challenging bearish sentiment.

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 28, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor.

The average of price targets set by Wall Street analysts indicates a potential upside of 25.1% in Hinge Health Inc. (HNGE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Hinge Health Inc. (HNGE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Hinge Health NYSE: HNGE reported first-quarter 2026 results that topped its prior outlook and raised its full-year guidance, citing stronger-than-expected member engagement, growth in eligible lives and continued operating leverage from artificial intelligence and automation.

Hinge Health beats Q1 estimates as revenues jump 47% and margins expand, while strong guidance and client growth drive a sharp after-hours stock jump.

Hinge Health, Inc. (HNGE) Q1 2026 Earnings Call Transcript

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the first quarter ended March 31, 2026. “We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes and lowers costs,” said Daniel Perez, Co-Founder and CEO, Hinge Health. “Based on this momentum, we're raising our full-year revenue outlook by approximat.

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today introduced its Migraine Care Program, offering rapid drug-free pain relief, personalized trigger management, and expert-led prevention for members. With meaningful overlap between the treatments and clinical best practices for migraine and musculoskeletal (MSK) care, Hinge Health is leveraging its proven expertise in nerve stimulation, exercise therapy, and behavior change to deliver comprehensive, whole-person care for peopl.